NextEra Energy (NEE)
(Delayed Data from NYSE)
$77.46 USD
-0.08 (-0.10%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $77.39 -0.07 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Price, Consensus and EPS Surprise
NEE 77.46 -0.08(-0.10%)
Will NEE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NEE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NEE
FE vs. NEE: Which Stock Is the Better Value Option?
Evergy (EVRG) Q2 Earnings Lag Estimates, Revenues Rise Y/Y
NEE: What are Zacks experts saying now?
Zacks Private Portfolio Services
NRG Energy (NRG) Q2 Earnings Beat Estimates, Sales Rise Y/Y
NiSource (NI) Q2 Earnings Surpass Estimates, Revenues Miss
Should You Invest in the Utilities Select Sector SPDR ETF (XLU)?
Other News for NEE
UTF: Utility And Infrastructure Fund With 7.6% Plus Income For The Long Term
The 3 Best Energy Stocks to Buy in August 2024
ClearBridge Global Infrastructure Value Strategy Q2 2024 Commentary
GUT: Examining The Fund's Changes Over The Past Few Months
Robert Bruce Amplifies Stake in AbbVie Inc, Highlighting Strategic Portfolio Adjustments in Q2 2024